反応 #2028890
ord-46f2d14b0ded4030b5d97d3fe7ebe57a
反応方程式
試薬
溶媒
反応条件
後処理
- 1その他A 100 mL three-necked round-bottomed flask equipped
- 2温度with reflux condenser, gas dispersion tube
- 3workup.STIRRINGThe solution was stirred at room temperature
- 4workup.STIRRINGThe solution was then stirred at room temperature for 1.25 hours
- 5抽出The solution was then extracted three times with ether
- 6洗浄the combined ethereal phase washed with brine
- 7乾燥dried over MgSO4
- 8ろ過filtered
- 9濃縮concentrated in vacuo
- 10その他to give a white solid
- 11その他that was recrystallized from ether/petroleum ether
実験手順
A 100 mL three-necked round-bottomed flask equipped with reflux condenser, gas dispersion tube and provisions for magnetic stirring was charged with 4-[5-(4-chlorophenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide (Example 1) (500 mg, 1.2 mmol) and 50 mL of glacial acetic acid. The solution was stirred at room temperature and treated with a stream of chlorine gas for a period of 15 minutes. The solution was then stirred at room temperature for 1.25 hours and then diluted with 100 mL of water. The solution was then extracted three times with ether and the combined ethereal phase washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to give a white solid that was recrystallized from ether/petroleum ether to provide 390 mg (75%) of 4-[5-(4-chlorophenyl)-4-chloro-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide: mp 180°-182° C.; 1H NMR (CDCl3/300 MHz) 7.97 (d, J=6.6Hz, 2H, 7.49 (d, 2H), 7.45 (d, J=6.3Hz, 2H), 7.25 (d, J=6.6Hz, 2H), 5.78 (brs, 2H).